Sector ratings Genmab A/S Nasdaq

Stocks

Real-time Estimate Cboe BZX 11:49:14 13/08/2026 pm IST			5-day change	1st Jan Change
31.31 ^USD	-0.35%		+5.16%	+1.85%

12/08	BNP Paribas Initiates Genmab at Outperform, With $40 Price Target	MT
12/08	Nordic stocks in North America: AstraZeneca fell 1.0%	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation
WUXI APPTEC CO., LTD.	7.01TCr		AAA
ARGENX SE	5.49TCr		A
INSMED INCORPORATED	2.89TCr	-	A	-		-
WUXI BIOLOGICS (CAYMAN) INC.	2.39TCr		AAA
BIONTECH SE	2.33TCr	-	-	-		-
PHARMAESSENTIA CORPORATION	1.84TCr		AA
GENMAB A/S	1.88TCr		A
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1.61TCr	-	AA	-		-
EXELIXIS, INC.	1.25TCr		BB
ARROWHEAD PHARMACEUTICALS, INC.	1.23TCr	-	BB	-		-
MADRIGAL PHARMACEUTICALS, INC.	1.24TCr	-	B	-		-
SUMMIT THERAPEUTICS INC.	1.2TCr	-	-	-		-
AKESO, INC.	1.2TCr		B			-
CYTOKINETICS, INCORPORATED	1.05TCr	-	AA	-		-
REMEGEN CO., LTD.	898.66Cr		-
SPYRE THERAPEUTICS, INC.	917.8Cr	-	BB	-	-	-
CRINETICS PHARMACEUTICALS, INC.	895.83Cr	-	BBB	-		-
VAXCYTE, INC.	887.62Cr	-	BBB	-		-
IMMUNITYBIO, INC.	820.31Cr	-	CCC	-		-
Average	1.95TCr		A
Weighted average by Cap.			A